top of page

Cyclo Therapeutics Media Release | May 30, 2024

  • Writer: ANPDF
    ANPDF
  • Jun 1, 2024
  • 1 min read

Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1


Read the full statement from Cyclo Therapeutics here:



Here is a summary of the article:


For more information about the Company’s TransportNPC™ pivotal Phase 3 study, visit www.ClinicalTrials.gov and reference identifier NCT04860960.

 

To join our fight, as well as fund vital research for a cure, support the Australian NPC Disease Foundation in its goals of "Research. Cure. Persevere."


Ways to support NP-C in Australia:

1 Comment

Rated 0 out of 5 stars.
No ratings yet

Add a rating
Guest
Jun 13, 2024
Rated 5 out of 5 stars.

At Penelope's Glass Artistry, we're not just in the business of selling glass art; we're on a mission to transform the way you perceive and experience art. My journey is a testament to the passion, creativity, and craftsmanship that go into every piece we create. Penelope's Glass Artistry isn't your typical glass art gallery. We're a sanctuary for those large glass sculpture for sale who appreciate art that transcends the ordinary. My creations are more than just glass; they are a marriage of skill, passion, and creativity. When you acquire a piece of glass art from us, you're taking home a slice of Penelope's heart and soul.

Like
ANPDF Logo

The ANPDF is dedicated to providing support and hope for a better future to all those living with Niemann-Pick disease.

  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • Youtube

We have so many exciting things going on,

be the first to find out!

Thanks for submitting!

©2024 by Australian NPC Disease Foundation Inc.

Australian NPC Disease Foundation Inc is registered with the Australian Tax Office as an Income Tax Exempt Charity. All donations over $2 are tax deductible.

ACNC-Registered-Charity-Logo_RGB
bottom of page